Skip to content
healthcare.dev
Get a free key

AMJEVITA

NDC 84612-482, adalimumab-atto, injection, from Nuvaila Limited.

Product NDC
84612-482
Status
Listed
Labeler
Nuvaila Limited
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761024
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84612-482 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB40 mg/.4mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
84612-482-01846120482011 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE
84612-482-02846120482022 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7862491-2634-4402-b001-dcc1abf8dd58

Use it

Look up 84612-482 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84612-482 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84612-482. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.